HealthStream director Linda Rebrovick sells $420,000 in stock

Linda Rebrovick, a director at HealthStream Inc. (NASDAQ:HSTM), sold 12,000 shares of the company’s common stock for a total value of $420,000. The transaction occurred on October 23, 2026.

The shares were sold at a price of $35.00 per share. Following this sale, Ms. Rebrovick directly holds 39,329 shares of HealthStream common stock.The sale comes as HealthStream stock trades near its 52-week high of $35.23, following a strong 65% surge over the past six months. With a P/E ratio of 48.37 and a market cap of $1.06 billion, InvestingPro analysis indicates the stock is currently overvalued relative to its Fair Value. Investors seeking deeper insights can access HealthStream’s comprehensive Pro Research Report, available for this and 1,400+ other US equities.

The sale was executed pursuant to a Rule 10b5-1 sales plan, which Ms. Rebrovick adopted on November 21, 2025.

In other recent news, HealthStream reported its second-quarter 2026 earnings, surpassing Wall Street expectations in both profit and revenue. The company achieved adjusted earnings of $0.23 per share, exceeding the forecast of $0.17, and reported revenue of $83.7 million, which was above the estimated $80.83 million. This marks a record quarterly revenue for HealthStream, reflecting a 12.5% increase from the previous year. In addition, Freedom Capital has initiated coverage on HealthStream with a Hold rating, setting a price target of $36.00. The research firm values HealthStream at three times its enterprise value to fiscal 2027 estimated revenue and 12 times its enterprise value to fiscal 2027 adjusted EBITDA. This valuation represents a slight premium compared to select comparable companies at 10 times EBITDA. These developments indicate a period of positive financial performance and cautious optimism from analysts regarding HealthStream’s future.